Ronald Chen

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

M. Ellis, J. Fleshman, Y. Tao, 2010, Cancer Chemotherapy and Pharmacology.

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

D. Fuller, T. Royce, A. Peddada, 2022, Frontiers in Oncology.

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

J. Picus, S. Tagawa, M. Taplin, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study combining UCN-01 with irinotecan in resistant solid tumor malignancies

J. Dancey, H. McLeod, J. Rader, 2004 .